Penetration of antibacterials into bone: pharmacokinetic, pharmacodynamic and bioanalytical considerations.
about
Pharmacokinetics and Dosing of Ceftobiprole Medocaril for the Treatment of Hospital- and Community-Acquired Pneumonia in Different Patient PopulationsTreatment algorithms for chronic osteomyelitisPharmacokinetics of ceftriaxone in plasma and bone of patients undergoing hip or knee surgery.Antibiotic stability over six weeks in aqueous solution at body temperature with and without heat treatment that mimics the curing of bone cementPenetration of daptomycin into bone and synovial fluid in joint replacement.Actinomycosis: etiology, clinical features, diagnosis, treatment, and managementClinical outcome of skin yaws lesions after treatment with benzathinebenzylpenicillin in a pygmy population in Lobaye, Central African Republic.Challenges in recognition and diagnosis of yaws in children in Papua New GuineaAntimicrobial activity against intraosteoblastic Staphylococcus aureus.A resorbable antibiotic-eluting polymer composite bone void filler for perioperative infection prevention in a rabbit radial defect modelA retrospective comparison of ceftriaxone versus oxacillin for osteoarticular infections due to methicillin-susceptible Staphylococcus aureusDaptomycin > 6 mg/kg/day as salvage therapy in patients with complex bone and joint infection: cohort study in a regional reference centerOutcome predictors in treatment of yaws.Pharmacokinetic and Pharmacodynamic Principles of Anti-infective Dosing.Teicoplanin-based antimicrobial therapy in Staphylococcus aureus bone and joint infection: tolerance, efficacy and experience with subcutaneous administration.Leuconostoc mesenteroides periprosthetic knee infection, an unusual fastidious Gram-positive bacteria: a case report.The management gram-negative bacterial haematogenous vertebral osteomyelitis: a case series of diagnosis, treatment and therapeutic outcomes.Penetration of moxifloxacin into bone evaluated by Monte Carlo simulation.In Vivo Efficacy of a "Smart" Antimicrobial Implant Coating.Bone penetration of amoxicillin and clavulanic acid evaluated by population pharmacokinetics and Monte Carlo simulationVancomycin-rifampin combination therapy has enhanced efficacy against an experimental Staphylococcus aureus prosthetic joint infection.Is Penicillin Plus Gentamicin Synergistic against Clinical Group B Streptococcus isolates?: An In vitro Study.Staphylococcus aureus-dependent septic arthritis in murine knee joints: local immune response and beneficial effects of vaccination.Long-term nonsense suppression therapy moderates MPS I-H disease progression.Pharmacotherapy of diabetic foot osteomyelitis.Prophylaxis and treatment of infections associated with penetrating traumatic injury.Osteomyelitis: an update for hospitalists.Current pharmacotherapy options for osteomyelitis: convergences, divergences and lessons to be drawn.Mycobacterium haemophilum bone and joint infection in HIV/AIDS: case report and literature review.Daptomycin, fosfomycin, or both for treatment of methicillin-resistant Staphylococcus aureus osteomyelitis in an experimental rat model.Optimal Duration of Antibiotic Therapy in Patients With Hematogenous Vertebral Osteomyelitis at Low Risk and High Risk of Recurrence.Treatment of Polymicrobial Osteomyelitis with Ceftolozane-Tazobactam: Case Report and Sensitivity Testing of Isolates.Bone and subcutaneous adipose tissue pharmacokinetics of vancomycin in total knee replacement patients.Septic arthritis of the hip in a Cambodian child caused by multidrug-resistant Salmonella enterica serovar Typhi with intermediate susceptibility to ciprofloxacin treated with ceftriaxone and azithromycin.[Vertebral osteomyelitis].A case of multifocal chronic Q fever osteomyelitis.In vitro activity of gentamicin as an adjunct to penicillin against biofilm group B Streptococcus.The Efficacy of Boric Acid Used to Treat Experimental Osteomyelitis Caused by Methicillin-Resistant Staphylococcus aureus: an In Vivo Study.Pristinamycin in the treatment of MSSA bone and joint infection.Staphylococcus aureus develops increased resistance to antibiotics by forming dynamic small colony variants during chronic osteomyelitis.
P2860
Q28066877-DAA44E07-2665-4C82-88BC-2266B138B4CFQ28730351-BF1F5EF0-09E7-452D-AD37-53443C3BDF15Q30317265-049FC37C-BCE5-44A5-9E1A-BBB4CF6CDF9DQ33759744-8E0EF831-8EDE-4605-8AD7-A435F11ECD17Q33798246-4DCA7B3E-4778-4DA1-860A-353943078FF9Q33890237-1C0B80F5-5D3D-464B-B02D-13AAD33878D1Q34101771-3254F48B-8610-4828-BAC2-E2FA60D4DC78Q35065615-4483610C-0EED-4375-B18F-36FCAA85C8CDQ35169047-F12A6B1E-F526-460D-8447-5C93D4787887Q35225221-A6471010-FD64-4FE2-9C3E-19E2DF50E4B2Q35745670-D8B91543-A1C6-4154-9D88-52866B6FB810Q35926840-8CD22125-6843-4035-9190-D8A097BDF7AFQ35997534-2821F7C3-E4AF-423C-8F6A-D13610C9A4FEQ36083619-CF3A3F8A-498E-4DA1-8CB9-06993026FCE3Q36181397-D884D493-14ED-4E30-B352-47EC3C943BB1Q36320970-7BFF2974-04BD-46A0-86B7-135AFA90B602Q37064474-051DF21E-DCDC-4583-84F6-DE94413640A2Q37190660-82977834-2106-4D0D-B7D5-463E15820FACQ37197429-82F2189B-BB19-45CF-8A72-BE97618D057DQ37204197-0D1CA8C3-A9C4-4D2E-B15F-A6E663DEF0F2Q37263918-697CE5A3-FA71-4345-8C61-59D8600523DDQ37356030-ED99A13C-091F-4AF5-998B-0EA738F05F23Q37454396-9F1A9AE5-C18F-435E-96E6-CD3BAB070F40Q37619694-5106DD2F-35CD-4B43-97CF-63811E949E51Q37642761-43B12FC0-89C4-4A97-BA2E-9BF0A0F75C33Q37822456-DB1ED132-1C84-47D6-B187-C6E05BEB6E2BQ37858380-A4194FA8-A75B-405C-9252-7A1F2CC411BDQ38089918-19B7923F-C6EE-4D97-8F49-A95F2898A871Q38313910-FD6D7AA0-59FE-485E-8719-88C2936B77BCQ38725968-265F6D02-48E0-4BFD-8ED5-8362BBBB210BQ38751083-E48B2AC5-3850-4AF4-B264-B2ED692FABA1Q39581980-F0C0C207-E7EA-4688-AF69-54BE2B5DB51EQ40044318-3DC06A12-009D-4969-8794-C3D6A5A49DA6Q40209769-1E50486D-010A-4E29-A01A-E23673B25142Q40248451-56F68624-F9E8-43E5-9723-3CAA756BD9F2Q40337738-652C432D-9354-43FF-840E-7C7BC1AE5F97Q40401533-194DAF48-CF52-4FB9-B713-22550D3777B4Q40761292-58A5A1A6-6046-460F-871B-69FB853A74A1Q40821374-4D125FBE-1FD0-4B7A-BE53-F101D4609B9EQ40901796-078A06FE-11DF-4C21-9FCC-E6BD5D82C849
P2860
Penetration of antibacterials into bone: pharmacokinetic, pharmacodynamic and bioanalytical considerations.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on January 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Penetration of antibacterials ...... bioanalytical considerations.
@en
Penetration of antibacterials ...... bioanalytical considerations.
@nl
type
label
Penetration of antibacterials ...... bioanalytical considerations.
@en
Penetration of antibacterials ...... bioanalytical considerations.
@nl
prefLabel
Penetration of antibacterials ...... bioanalytical considerations.
@en
Penetration of antibacterials ...... bioanalytical considerations.
@nl
P2860
P50
P1476
Penetration of antibacterials ...... bioanalytical considerations.
@en
P2093
Fritz Sörgel
Martina Kinzig
P2860
P304
P356
10.2165/00003088-200948020-00002
P577
2009-01-01T00:00:00Z
P6179
1018924295